Generic Premarin?
Executive Summary
Barr submits ANDA for conjugated estrogens (Wyeth's Premarin) June 27. FDA has not yet accepted the application. A suit between Wyeth and Barr's ingredient supplier for the generic has not yet been resolved (1"The Pink Sheet" Jan. 27, 2003, p. 25)...
You may also be interested in...
Barr’s Generic Premarin ANDA To Be Filed By June; Cenestin Sales Growing
Barr Laboratories plans to submit an ANDA for generic Premarin (conjugated estrogens) by June without waiting for a decision in Wyeth's suit against Barr's ingredient supplier
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.